Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
Market Cap
$168.66M
Net Profit Margin
-170.10%
TTM Avg
-145.13%
3Y Avg
-100.04%
5Y Avg
-83.24%
Market Cap
$169.85M
Net Profit Margin
-19.76%
TTM Avg
3.38%
3Y Avg
2.83%
5Y Avg
6.10%
Market Cap
$170.21M
Net Profit Margin
-435.83%
TTM Avg
-267.41%
3Y Avg
-1429.19%
5Y Avg
-1238.68%
Market Cap
$171.26M
Net Profit Margin
-117.04%
TTM Avg
-61.51%
3Y Avg
-173.42%
5Y Avg
-194.84%
Market Cap
$165.66M
Net Profit Margin
4.66%
TTM Avg
-8.57%
3Y Avg
-15.00%
5Y Avg
-10.75%
Market Cap
$163.69M
Net Profit Margin
-80.29%
TTM Avg
-52.87%
3Y Avg
-55.88%
5Y Avg
-51.71%
Market Cap
$173.76M
Net Profit Margin
-229.20%
TTM Avg
-206.03%
3Y Avg
-659.07%
5Y Avg
-1951.89%
Market Cap
$173.52M
Net Profit Margin
-8.95%
TTM Avg
-22.31%
3Y Avg
-22.43%
5Y Avg
-24.59%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nkarta, Inc. (NKTX) | $168.49M | 0.00% | 0.00% | 0.00% | 0.00% |
| MediWound Ltd. (MDWD)vs › | $168.66M | -170.10% | -145.13% | -100.04% | -83.24% |
| Organogenesis Holdings Inc. (ORGO)vs › | $169.85M | -19.76% | 3.38% | 2.83% | 6.10% |
| Cue Biopharma, Inc. (CUE)vs › | $170.21M | -435.83% | -267.41% | -1429.19% | -1238.68% |
| Precision BioSciences, Inc. (DTIL)vs › | $171.26M | -117.04% | -61.51% | -173.42% | -194.84% |
| OptimizeRx Corp. (OPRX)vs › | $165.66M | 4.66% | -8.57% | -15.00% | -10.75% |
| Quanterix Corporation (QTRX)vs › | $163.69M | -80.29% | -52.87% | -55.88% | -51.71% |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.76M | -229.20% | -206.03% | -659.07% | -1951.89% |
| Journey Medical Corporation (DERM)vs › | $173.52M | -8.95% | -22.31% | -22.43% | -24.59% |
| Coherus Oncology, Inc. (CHRS)vs › | $163.00M | -257.10% | -196.56% | -155.96% | -114.00% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | -2723853.25% |
| 2019-09-30 | 692987.01% |
| 2019-06-30 | -209616.77% |
| 2019-03-31 | -2726.44% |
